Find clinical trials for Ovarian Cancer in Washington, DC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Washington, DC, USA:
of the study drugs fostamatinib and paclitaxel. This study tests different doses of the drugs to see which doses are safest in people with ovarian...
Phase 1
Washington, District of Columbia, United States and 2 other locations
Gleolan for the real-time detection and visualization of epithelial ovarian cancer tumors during debulking surgery. The st...
Phase 3
Annapolis, Maryland, United States
cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objecti ...
Phase 3
Silver Spring, Maryland, United States and 23 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Baltimore, Maryland, United States and 125 other locations
(CAR) T cells developed by Precigen, Inc.) in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has...
Phase 1
Bethesda, Maryland, United States and 1 other location
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Towson, Maryland, United States and 213 other locations
carcinoma 1 (NY-ESO-1) peptide vaccine as a priming mechanism to prevent anti-PD1 resistance in patients with platinum-refractory stage III/IV ovarian...
Phase 2
Washington, District of Columbia, United States and 1 other location
the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...
Phase 2
Glenn Dale, Maryland, United States and 46 other locations
(PK), and pharmacodynamics (PD) of ZN-c3 in combination with niraparib and of ZN-c3 Monotherapy in subjects with platinum-resistant ovarian ....
Phase 1, Phase 2
Fairfax, Virginia, United States and 19 other locations
Phase 1 trial to study the safety, pharmacokinetic and Preliminary Efficacy of STRO-002 in combination with Bevacizumab.
Phase 1
Fairfax, Virginia, United States and 5 other locations
Clinical trials
Research sites
Resources
Legal